Kunadt D, Zukunft S, Rollig C, Metzelder S, et al. Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study. Br J Haematol 2026;209:1783-1796.
PMID: 42610785